Hendriks, Rianne J.
van der Leest, Marloes M. G.
Israël, Bas http://orcid.org/0000-0003-4848-4537
Hannink, Gerjon http://orcid.org/0000-0001-9526-3775
YantiSetiasti, Anglita
Cornel, Erik B.
Hulsbergen-van de Kaa, Christina A.
Klaver, O. Sjoerd
Sedelaar, J. P. Michiel
Van Criekinge, Wim
de Jong, Hans http://orcid.org/0000-0001-6559-6659
Mulders, Peter F. A.
Crawford, E. David
Veltman, Jeroen
Schalken, Jack A. http://orcid.org/0000-0001-8274-7797
Barentsz, Jelle O. http://orcid.org/0000-0003-0366-2184
van Oort, Inge M. http://orcid.org/0000-0002-8002-1869
Funding for this research was provided by:
KWF Kankerbestrijding (KUN 2015-6707)
Article History
Received: 19 November 2020
Revised: 17 March 2021
Accepted: 23 March 2021
First Online: 3 May 2021
Compliance with ethical standards
:
: IMO and JOB certify that all conflicts of interest, including specific financial interests and relationships and affiliations relevant to the subject matter or materials discussed in the manuscript (e.g., employment/affiliation, grants or funding, consultancies, honoraria, stock ownership or options, expert testimony, royalties, or patents filed, received, or pending), are the following: JAS, WVC, HJ, and EDC are employees of or consultants for MDxHealth and may have stock or stock options, IMO is a member of the editorial board of the website prostateMDx.org, owned by MDxHealth. The other authors declare no competing interests.
: The study was performed in accordance with the Declaration of Helsinki. All participants gave written informed consent and the study was approved by the ethics committee. The trial was registered in the Netherlands Trial Register, identifier NTR5555 (trialregister.nl).